Thus, we conclude that the cancer-derived SORBS2-stabilized secretome could potently suppress ovarian cancer metastasis and modulate the accumulation of tumor-promoting myeloid cells in vivo (Fig. 9e, f). This evidence concerns the gene SORBS2 and ovarian cancer.